Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Anti-murine CD52 Antibody Treatment Does Not Adversely Affect the Migratory Ability of Immune Cells
Multiple Sclerosis
(-)
222
Authors/Disclosures

PRESENTER 		No disclosure on file
Michael J. Turner, PhD (Sanofi Genzyme) No disclosure on file
No disclosure on file
Randolph S. Marshall, MD, FÂ鶹´«Ã½Ó³»­ (Columbia University) The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
No disclosure on file
Lamya Shihabuddin, PhD (Genzyme Corporation) No disclosure on file
Bruce Roberts, PhD No disclosure on file
Johanne M. Kaplan, PhD (ProMIS Neurosciences) Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
William M. Siders, PhD No disclosure on file